for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Cronos Group Inc

CRON.TO

Latest Trade

4.85CAD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

4.75

 - 

20.08

As of on the Toronto Stock Exchange ∙ Minimum 15 minute delay

Pricing

Previous Close
4.85
Open
--
Volume
--
3M AVG Volume
10.26
Today's High
--
Today's Low
--
52 Week High
20.08
52 Week Low
4.75
Shares Out (MIL)
371.81
Market Cap (MIL)
1,830.38
Forward P/E
-8.83
Dividend (Yield %)
--

Next Event

Q4 2021 Cronos Group Inc Earnings Release

Latest Developments

More

Aurora And 22nd Century Group License Foundational Biosynthesis IP To Cronos Group

Cronos Group Determined It Will Be Required To Restate Interim Financial Statements For 3 & 6 Months Ended June 30, 2021

Cronos Group Appoints Bob Madore As Chief Financial Officer

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Cronos Group Inc

Cronos Group Inc. is a cannabinoid company. The Company is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

Industry

Biotechnology & Drugs

Contact Info

111 Peter Street, Unit 300

TORONTO, ON

M5V2H1

Canada

+1.416.5040004

https://thecronosgroup.com/

Executive Leadership

Michael Ryan Gorenstein

Executive Chairman of the Board

Kurt T. Schmidt

President, Chief Executive Officer

Robert L. Madore

Chief Financial Officer

Xiuming Shum

Executive Vice President, Legal and Regulatory Affairs

Shannon Buggy

Senior Vice President, Global Head of People

Key Stats

3.25 mean rating - 12 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020

0.0K

2021(E)

0.1K
EPS (USD)

2018

-0.081

2019

3.330

2020

-0.210

2021(E)

-0.441
Price To Earnings (TTM)
--
Price To Sales (TTM)
25.74
Price To Book (MRQ)
0.89
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
0.00
LT Debt To Equity (MRQ)
0.00
Return on Investment (TTM)
-8.87
Return on Equity (TTM)
-7.84

Latest News

Latest News

BRIEF-Cronos Group Reports 2020 First Quarter Results

* CRONOS GROUP INC - QTRLY CONSOLIDATED NET REVENUE $8.43 MILLION VERSUS $3 MILLION

Altria CEO Howard Willard steps down, finance head to succeed

Altria Group Inc <MO.N> said on Friday Chief Executive Officer Howard Willard has stepped down, ending a near two-year tumultuous term at the helm marked by heightened scrutiny of the tobacco giant's bet on e-cigarette maker Juul.

BRIEF-Cronos Group Says In Accordance With Investor Rights Agreement And Altria's Submission, Board Elected Heather Newman As A Director

* CRONOS GROUP - IN ACCORDANCE WITH INVESTOR RIGHTS AGREEMENT AND ALTRIA'S SUBMISSION, BOARD ELECTED HEATHER NEWMAN AS A DIRECTOR Source text: (https://bit.ly/39ZeNnv) Further company coverage:

BRIEF-Cronos Group To Restate Certain 2019 Unaudited Interim Financial Statements

* CRONOS GROUP TO RESTATE CERTAIN 2019 UNAUDITED INTERIM FINANCIAL STATEMENTS

BRIEF-Cronos Group To Delay 2019 Q4 And Full-Year Earnings Release And Conference Call

* CRONOS GROUP TO DELAY 2019 Q4 AND FULL-YEAR EARNINGS RELEASE AND CONFERENCE CALL

Pot producers Cronos and Tilray report lower prices, soaring expenses

Cronos Group Inc <CRON.TO> <CRON.N> and Tilray Inc <TLRY.O> both reported selling prices that nearly halved, while expenses for both the Canadian pot producers soared in the third quarter.

Pot company Cronos Group posts bigger quarterly loss

Cronos Group Inc reported a bigger quarterly loss on Tuesday, as the Canadian marijuana producer was weighed down by lower margins and surge in expenses.

Pot company Cronos warns of wider second-half loss on higher costs; shares tumble

Canada's Cronos Group <CRON.TO> shares reversed course to trade down after the pot company forecast a wider second-half loss compared to the first, even as sales soar, as it spends on developing new products and expanding abroad.

Pot company Cronos posts wider loss as expenses soar

Canadian marijuana company Cronos Group reported a wider quarterly core loss on Thursday, as it struggled with rising costs.

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up